Surufatinib plus toripalimab in patients with advanced neuroendocrine tumours and neuroendocrine carcinomas: An open-label, single-arm, multi-cohort phase II trial

Panpan Zhang, Si Shi, Jianming Xu, Zhendong Chen, Lijie Song, Xing Zhang, Ying Cheng, Yanqiao Zhang, Feng Ye, Zhiping Li, Fei Yin, Dongmei Ji, Heli Gao, Yi Li, Wei J. Chen, Minjie Yang, Desheng Weng, Chunjiao Wu, Yue Ma, Wang Sheng, Yaqin Zhao, Xiaolei Yin, Weina Shen, Weiguo Su, Michael Shi, Songhua Fan, Panfeng Tan, Qian Xu, Ming Lu, Lin Shen